Skip to main content

U.S. a big winner if Canada-EU sign trade deal

The following is excerpted from the 24 September 2012 edition of The Globe and Mail.

Negotiations resumed in Ottawa last week to move the Canada-EU Comprehensive Economic and Trade (CETA) deal forward. Europe continues to push Canada on pharmaceutical patents, urging Ottawa to adopt higher standards than the EU is itself even willing to embrace. So far, Canada has refused to agree.

The public debate surrounding CETA has not looked closely enough at the consequences of providing the greater patent protection for brand-name drugs that the Europeans are demanding.

This article is available in its entirety at:
http://www.theglobeandmail.com/report-on-business/economy/economy-lab/us-a-big-winner-if-canada-eu-sign-trade-deal/article4562985/

Topic(s)

Trade Agreements

Information source

Canadian News Channel
Disclaimer

The foregoing information is provided for informational purposes only and is not intended as, nor should it be considered, professional advice or a substitute for conducting your own thorough research and review. Before making any decisions or taking any action based on the information provided, you should conduct your own independent investigation and/or seek professional advice from a qualified expert in the relevant field. The CSCB disclaims all liability for actions taken or not taken based on the information provided.